Abstract
Urinary incontinence (UI) is defined as the involuntary loss of urine. It is common, under-reported, and morbid. More so in older adults than in younger adults, urinary incontinence may be multifactorial and is therefore considered among geriatric syndromes. For this reason, typical clinical symptom-based approaches may be subeffective and potentially harmful. In this chapter, we approach the problem by proposing that understanding incontinence first requires understanding the determinants of social urinary continence. Unlike standard bladder-centric clinical approaches, incontinence extends beyond the aging lower urinary tract. Urinary incontinence rarely occurs as an isolated problem in older patients. Considerations are proposed to help identify the factors that contribute to incontinence in the individual patient, and patient-center approaches to managing bladder control disorders in older adults are reviewed.
Phillip P. Smith: deceased.
Authors would like to dedicate this chapter to the memory and legacy of our colleague, collaborator and friend Dr Phil Smith
References
DuBeau CE. Beyond the bladder: management of urinary incontinence in older women. Clin Obstet Gynecol. 2007;50(3):720–34.
Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc. 1998;46(4):473–80.
Buckley BS, Lapitan MC. Epidemiology committee of the fourth international consultation on incontinence P. prevalence of urinary incontinence in men, women, and children – current evidence: findings of the Fourth International Consultation on Incontinence. Urology. 2010;76(2):265–70.
Offermans MP, Du Moulin MF, Hamers JP, Dassen T, Halfens RJ. Prevalence of urinary incontinence and associated risk factors in nursing home residents: a systematic review. Neurourol Urodyn. 2009;28(4):288–94.
Nelson HD, Cantor A, Pappas M, Miller L. Screening for urinary incontinence in women: a systematic review for the women’s preventive services initiative. Ann Intern Med. 2018;169(5):311–9.
O’Reilly N, Nelson HD, Conry JM, Frost J, Gregory KD, Kendig SM, et al. Screening for urinary incontinence in women: a recommendation from the women’s preventive services initiative. Ann Intern Med. 2018;169(5):320–8.
Thor KB, Donatucci C. Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women. J Urol. 2004;172(1):27–33.
McAninch JW, Lue TF. Smith & Tanagho’s general urology. 18th ed. The McGraw-Hill.
Griffiths DJ. Urodynamics. The mechanics of hydrodynamics of the lower urinary tract. Bristol: Hilger; 1980.
Blok BF, Willemsen AT, Holstege G. A PET study on brain control of micturition in humans. Brain. 1997;120(Pt 1):111–21.
le Feber J, van Asselt E, van Mastrigt R. Afferent bladder nerve activity in the rat: a mechanism for starting and stopping voiding contractions. Urol Res. 2004;32(6):395–405.
Vaughan CP, Markland AD, Smith PP, Burgio KL, Kuchel GA, The American Geriatrics Society/National Institute on Aging Urinary Incontinence Conference Planning C, et al. Report and research agenda of the American geriatrics society and national institute on aging bedside-to-bench conference on urinary incontinence in older adults: a translational research agenda for a complex geriatric syndrome. J Am Geriatr Soc. 2018;66(4):773–82.
Schaffer J, Nager CW, Xiang F, Borello-France D, Bradley CS, Wu JM, et al. Predictors of success and satisfaction of nonsurgical therapy for stress urinary incontinence. Obstet Gynecol. 2012;120(1):91–7.
Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J. 2017;28(5):687–96.
Komesu YM, Schrader RM, Ketai LH, Rogers RG, Dunivan GC. Epidemiology of mixed, stress, and urgency urinary incontinence in middle-aged/older women: the importance of incontinence history. Int Urogynecol J. 2016;27(5):763–72.
Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc. 2007;55(5):780–91.
Campbell Walsh Wein Urology. 12th ed.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.
Smith PP. Aging and the underactive detrusor: a failure of activity or activation? Neurourol Urodyn. 2010;29(3):408–12.
Young JS, Johnston L, Soubrane C, McCloskey KD, McMurray G, Eccles R, et al. The passive and active contractile properties of the neurogenic, underactive bladder. BJU Int. 2013;111(2):355–61.
Chancellor MB. The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol. 2014;46(Suppl 1):23–7.
Tyagi P, Kashyap M, Majima T, Kawamorita N, Yoshizawa T, Yoshimura N. Intravesical liposome therapy for interstitial cystitis. Int J Urol. 2017;24(4):262–71.
Resnick NM, Elbadawi A, Yalla SV. Age and the lower urinary tract: what is normal? (abstract). Neurourol Urodyn. 1995;14:577–9.
Leitner L, Walter M, Sammer U, Knupfer SC, Mehnert U, Kessler TM. Urodynamic investigation: a valid tool to define normal lower urinary tract function? PLoS One. 2016;11(10):e0163847.
Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213–40.
Betschart C, Scheiner D, Maake C, Vich M, Slomianka L, Fink D, et al. Histomorphological analysis of the urogenital diaphragm in elderly women: a cadaver study. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1477–81.
Saatli B, Kizildag S, Cagliyan E, Dogan E, Saygili U. Alteration of apoptosis-related genes in postmenopausal women with uterine prolapse. Int Urogynecol J. 2014;25(7):971–7.
Strasser H, Tiefenthaler M, Steinlechner M, Bartsch G, Konwalinka G. Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells. Lancet. 1999;354(9182):918–9.
Zhou Y, Liu X, Li W, Sun X, Xie Z. Endoplasmic reticulum stress contributes to the pathogenesis of stress urinary incontinence in postmenopausal women. J Int Med Res. 2018;46(12):5269–77.
Waetjen LE, Ye J, Feng WY, Johnson WO, Greendale GA, Sampselle CM, et al. Association between menopausal transition stages and developing urinary incontinence. Obstet Gynecol. 2009;114(5):989–98.
Silva LA, Andriolo RB, Atallah AN, da Silva EM. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev. 2014;9:CD008306.
Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol. 1993;150(5 Pt 2):1657–67.
Lowalekar SK, Cristofaro V, Radisavljevic ZM, Yalla SV, Sullivan MP. Loss of bladder smooth muscle caveolae in the aging bladder. Neurourol Urodyn. 2012;31(4):586–92.
Fry CH, Bayliss M, Young JS, Hussain M. Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle. BJU Int. 2011;108(2 Pt 2):E91–6.
Miyata Y, Matsuo T, Mitsunari K, Asai A, Ohba K, Sakai H. A review of oxidative stress and urinary dysfunction caused by bladder outlet obstruction and treatments using antioxidants. Antioxidants (Basel). 2019;8(5):132.
Suskind AM. The aging overactive bladder: a review of aging-related changes from the brain to the bladder. Curr Bladder Dysfunct Rep. 2017;12(1):42–7.
Collas DM, Malone-Lee JG. Age-associated changes in detrusor sensory function in women with lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(1):24–9.
Richter HE, Morgan SL, Gleason JL, Szychowski JM, Goode PS, Burgio KL. Pelvic floor symptoms and bone mineral density in women undergoing osteoporosis evaluation. Int Urogynecol J. 2013;24(10):1663–9.
Talasz H, Jansen SC, Kofler M, Lechleitner M. High prevalence of pelvic floor muscle dysfunction in hospitalized elderly women with urinary incontinence. Int Urogynecol J. 2012;23(9):1231–7.
Resnick NM, Yalla SV. Management of urinary incontinence in the elderly. N Engl J Med. 1985;313(13):800–5.
Sakakibara R, Uchiyama T, Yamanishi T, Kishi M. Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population. Int J Urol. 2008;15(9):778–88.
Fox C, Smith T, Maidment I, Chan WY, Bua N, Myint PK, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014;43(5):604–15.
Moga DC, Carnahan RM, Lund BC, Pendergast JF, Wallace RB, Torner JC, et al. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers. J Am Med Dir Assoc. 2013;14(10):749–60.
Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175(3):401–7.
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019;179:1084.
Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361:k1315.
Balk EM, Rofeberg VN, Adam GP, Kimmel HJ, Trikalinos TA, Jeppson PC. Pharmacologic and nonpharmacologic treatments for urinary incontinence in women: a systematic review and network meta-analysis of clinical outcomes. Ann Intern Med. 2019;170(7):465–79.
Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One. 2009;4(1):e4144.
Han TS, Tajar A, Lean ME. Obesity and weight management in the elderly. Br Med Bull. 2011;97:169–96.
Patel M, Coshall C, Rudd AG, Wolfe CD. Natural history and effects on 2-year outcomes of urinary incontinence after stroke. Stroke. 2001;32(1):122–7.
Cassel CK, Leipzig RM, Cohen HJ, Larson EB, Meier DE, Capello CF. Geriatric medicine: an evidence-based approach. New York: Springer; 2003. https://doi.org/10.1007/b97639.
Powell CR. Not all neurogenic bladders are the same: a proposal for a new neurogenic bladder classification system. Transl Androl Urol. 2016;5(1):12–21.
Sakakibara R, Kanda T, Sekido T, Uchiyama T, Awa Y, Ito T, et al. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn. 2008;27(6):507–10.
Panicker JN, Fowler CJ, Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol. 2015;14(7):720–32.
Stoffel JT. Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Transl Androl Urol. 2016;5(1):127–35.
Taweel WA, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85–99.
Rossier AB, Fam BA, Dibenedetto M, Sarkarati M. Urodynamics in spinal shock patients. J Urol. 1979;122(6):783–7.
Fowler CJ. Neurological disorders of micturition and their treatment. Brain. 1999;122(Pt 7):1213–31.
Gupta A, Rashmi Krishnan UK, Nageshkumar S, Pal PK, Khanna M, Taly AB. Urinary symptoms in patients with Parkinson’s disease and progressive supranuclear palsy: urodynamic findings and management of bladder dysfunction. Ann Indian Acad Neurol. 2019;22(4):432–6.
Chancellor MB, Blaivas JG. Urological and sexual problems in multiple sclerosis. Clin Neurosci. 1994;2(3–4):189–95.
Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology. 1993;43(12):2632–7.
Vaughan CP, Markland AD. Urinary incontinence in women. Ann Intern Med. 2020;172(3):ITC17–32.
NICE. Guidance – Urinary incontinence and pelvic organ prolapse in women: management: (c) NICE (2019) Urinary incontinence and pelvic organ prolapse in women: management. BJU Int. 2019;123(5):777–803.
Hu JS, Pierre EF. Urinary incontinence in women: evaluation and management. Am Fam Physician. 2019;100(6):339–48.
Parker WP, Griebling TL. Nonsurgical treatment of urinary incontinence in elderly women. Clin Geriatr Med. 2015;31(4):471–85.
Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, et al. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med. 2006;144(10):715–23.
Irwin GM. Urinary incontinence. Prim Care. 2019;46(2):233–42.
Johnson TM 2nd, Vaughan CP. Urological function and dysfunction in aging: diagnosis and treatment. Handb Clin Neurol. 2019;167:495–509.
Cameron AP, Wiseman JB, Smith AR, Merion RM, Gillespie BW, Bradley CS, et al. Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort. Neurourol Urodyn. 2019;38(8):2185–93.
Parsons M, Amundsen CL, Cardozo L, Vella M, Webster GD, Coats AC, et al. Bladder diary patterns in detrusor overactivity and urodynamic stress incontinence. Neurourol Urodyn. 2007;26(6):800–6.
Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. Urinary incontinence in women: a review. JAMA. 2017;318(16):1592–604.
Smith PP, Kuchel GA. Clinical meaning of a high postvoid residual: when the value of a result is less and more than one would expect. J Am Geriatr Soc. 2015;63(7):1432–4.
Yono M, Ito K, Oyama M, Tanaka T, Irie S, Matsukawa Y, et al. Variability of post-void residual urine volume and bladder voiding efficiency in patients with underactive bladder. Low Urin Tract Symptoms. 2020;13:51.
Sussman RD, Syan R, Brucker BM. Guideline of guidelines: urinary incontinence in women. BJU Int. 2020;125(5):638–55.
Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE. What type of urinary incontinence does this woman have? JAMA. 2008;299(12):1446–56.
Harvey MA, Versi E. Predictive value of clinical evaluation of stress urinary incontinence: a summary of the published literature. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(1):31–7.
Wagg A, Gibson W, Ostaszkiewicz J, Johnson T 3rd, Markland A, Palmer MH, et al. Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence. Neurourol Urodyn. 2015;34(5):398–406.
Syan R, Brucker BM. Guideline of guidelines: urinary incontinence. BJU Int. 2016;117(1):20–33.
Narayanan S, Cerulli A, Kahler KH, Ouslander JG. Is drug therapy for urinary incontinence used optimally in long-term care facilities? J Am Med Dir Assoc. 2007;8(2):98–104.
Subak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481–90.
Wing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, et al. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010;184(3):1005–10.
Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn. 2008;27(8):749–57.
Yazdany T, Jakus-Waldman S, Jeppson PC, Schimpf MO, Yurteri-Kaplan LA, Ferzandi TR, et al. American urogynecologic society systematic review: the impact of weight loss intervention on lower urinary tract symptoms and urinary incontinence in overweight and obese women. Female Pelvic Med Reconstr Surg. 2020;26(1):16–29.
Imamura M, Williams K, Wells M, McGrother C. Lifestyle interventions for the treatment of urinary incontinence in adults. Cochrane Database Syst Rev. 2015;12:CD003505.
Burgio KL, Locher JL, Goode PS, Hardin JM, McDowell BJ, Dombrowski M, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA. 1998;280(23):1995–2000.
Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10:CD005654.
Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD, Shekelle P, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014;161(6):429–40.
Hay-Smith EJ, Herderschee R, Dumoulin C, Herbison GP. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2011;12:CD009508.
Herbison GP, Dean N. Weighted vaginal cones for urinary incontinence. Cochrane Database Syst Rev. 2013;7:CD002114.
Herderschee R, Hay-Smith EJ, Herbison GP, Roovers JP, Heineman MJ. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2011;7:CD009252.
Ouslander JG, Schnelle JF, Uman G, Fingold S, Nigam JG, Tuico E, et al. Predictors of successful prompted voiding among incontinent nursing home residents. JAMA. 1995;273(17):1366–70.
Ouslander JG, Schnelle JF. Incontinence in the nursing home. Ann Intern Med. 1995;122(6):438–49.
Schnelle JF. Treatment of urinary incontinence in nursing home patients by prompted voiding. J Am Geriatr Soc. 1990;38(3):356–60.
Eustice S, Roe B, Paterson J. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2000;2:CD002113.
Ouslander JG, Griffiths PC, McConnell E, Riolo L, Kutner M, Schnelle J. Functional incidental training: a randomized, controlled, crossover trial in veterans affairs nursing homes. J Am Geriatr Soc. 2005;53(7):1091–100.
Ostaszkiewicz J, Johnston L, Roe B. Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2004;1:CD002802.
Ostaszkiewicz J, Johnston L, Roe B. Habit retraining for the management of urinary incontinence in adults. Cochrane Database Syst Rev. 2004;2:CD002801.
Cui Y, Zong H, Yang C, Yan H, Zhang Y. The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials. Int Urol Nephrol. 2014;46(1):275–84.
Sebastianelli A, Russo GI, Kaplan SA, McVary KT, Moncada I, Gravas S, et al. Systematic review and meta-analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: comparison with placebo and tolterodine. Int J Urol. 2018;25(3):196–205.
Mirabegron (Myrbetriq) for overactive bladder. Med Lett Drugs Ther. 2013;55(1410):13–5.
Mariappan P, Ballantyne Z, N’Dow JM, Alhasso AA. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev. 2005;3:CD004742.
Wolff GF, Kuchel GA, Smith PP. Overactive bladder in the vulnerable elderly. Res Rep Urol. 2014;6:131–8.
Santos-Silva A, da Silva CM, Cruz F. Botulinum toxin treatment for bladder dysfunction. Int J Urol. 2013;20(10):956–62.
White WM, Pickens RB, Doggweiler R, Klein FA. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population. J Urol. 2008;180(6):2522–6.
van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama A, Nijholt AA, Siegel S, Jonas U, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol. 2007;178(5):2029–34.
McAchran SE, Daneshgari F. Sacral neuromodulation in the older woman. Clin Obstet Gynecol. 2007;50(3):735–44.
White WM, Mobley JD 3rd, Doggweiler R, Dobmeyer-Dittrich C, Klein FA. Sacral nerve stimulation for refractory overactive bladder in the elderly population. J Urol. 2009;182(4):1449–52.
Amundsen CL, Webster GD. Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol. 2002;187(6):1462–5. discussion 5
Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66(4):746–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Appendices
Appendix A
Appendix B
Appendix C: Office Cystometry Procedure and Interpretation
Procedure
-
1.
Supplies at the ready: 14 or 16 Fr. Catheter. 500 ml of sterile water or saline. A Toomey syringe (or equivalent, with a catheter tip and at least 50 ml capacity). Clean gloves, tissues, lubricant. Kidney basin (to catch postvoid volume).
-
2.
Explain the procedure and obtain verbal consent. This is same risk and discomfort as a straight catheterization to drain the bladder in a clinic examination room; therefore, consent process should follow institutional practice (verbal vs. written).
-
3.
Have patient void the bladder as usual.
-
4.
Patient undresses, waste down.
-
5.
Gross contamination is cleansed from the urethral meatus. Antisepsis is not required and may irritate urethral outlet.
-
6.
Operator wears clean exam gloves. The tip of a sterile 14 or 16 Fr catheter (latex, or silicon if allergic to latex) is lubricated with clinical lubricant, and the catheter is passed into the bladder. Collect and record the post void residual volume. Urine may be sent for culture or microscopic examination as needed.
-
7.
Remove the plunger or bulb from the syringe and attach to the catheter.
-
8.
Hold the syringe body about 15 cm (6 inches) above pubic symphasis and pour in about 50 ml of fluid, raise syringe as needed to observe fluid flowing into the bladder (syringe volume declines).
-
9.
Ask the patient to report when they feel something in the bladder; the patient should be quiet (no conversation) to avoid increases in bladder pressure due to transmitted increases in intra-abdominal pressure.
-
10.
When this is complete, refill the syringe and allow fluid inflow to start, but then lower syringe until fluid flow stops. If fluid backs up into the syringe, raise it until volume in syringe is stable. Estimate distance from top of fluid in syringe to pubic symphasis; this is the “low volume pressure” (i.e., if 15 cm above symphysis, “low volume pressure” is 15 cm of water).
-
11.
Raise syringe about 5 cm above this level and continue to fill bladder, refilling the syringe as needed. Observe fluid level drop in the syringe as the bladder fills.
-
12.
If column “bounces” (i.e., stops/starts, or even temporarily rises), and the patient is not talking/straining/valsalva’ing, “detrusor overactivity” (DO) can be suspected. Record volume and any accompanying reported sensations.
-
13.
Repeat syringe filling until patient reports some desire to void. Raise/lower syringe to stabilize column height and measure height of fluid column above symphysis; this is “high volume pressure.” Record this pressure and the volume infused.
-
14.
Remove catheter and ask patient to Valsalva and/or cough, observing meatus for any leakage (stand to the side and have a tissue positioned in case leakage happens).
Interpretation
-
First sensation and voiding sensation assess patient’s awareness of bladder. In our experience, first sensation is typically around 50 ml, and voiding sensation at office cystometry is typically around 250–300 ml.
-
Presence or absence of DO can help to understand the cause of incontinence and/or symptoms of urgency. Sensed DO may underlie urgency, whereas leakage may occur with either sensed or non-sensed DO.
-
Calculate Compliance as difference between high and low volume divided by difference between high and low volume pressures (e.g., (250 ml – 50 ml)/(17 cm – 15 cm) = 100 ml/cm of water. Values below 40 should be concerning, and values below 20 should be considered for urologic referral.
-
If no DO was observed but the patient leaks with Valsalva or cough at “high volume,” sphincteric insufficiency can be strongly suspected as a cause for incontinence. If DO was observed, this is not a safe assumption.
Rights and permissions
Copyright information
© 2024 Springer Nature Switzerland AG
About this entry
Cite this entry
Wright, L.A., Hamilton, P., Kuchel, G.A., Smith, P.P. (2024). Voiding Problems and Urinary Incontinence in the Geriatric Patient. In: Wasserman, M.R., Bakerjian, D., Linnebur, S., Brangman, S., Cesari, M., Rosen, S. (eds) Geriatric Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-74720-6_115
Download citation
DOI: https://doi.org/10.1007/978-3-030-74720-6_115
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-74719-0
Online ISBN: 978-3-030-74720-6
eBook Packages: MedicineReference Module Medicine